|
|
|
| |
|
|
| |
The latest pharmaceutical manufacturing news from News Medical |
|
|
|
 | | |
 How can you improve your PEI-based transient transfection process?
Discover how recent innovations are revolutionizing PEI-assisted transfection in viral vector manufacturing. From SR-DLS analytics to stabilizers and automated complex formation, new data-driven approaches are boosting transfection efficiency, yield, and reproducibility while cutting costs and waste. Explore how these advances are redefining upstream processing for next-generation biomanufacturing.
| |
|
|
|  | | |
| |
|
 How Biological Safety Cabinets differ from Laminar Flow Cabinets
Controlled laboratory environments play a critical role in biological, clinical, pharmaceutical, and research settings to safeguard product quality, ensure operator safety, and protect the surrounding environment. Two commonly employed systems for achieving these goals are Biological Safety Cabinets (BSCs) and Laminar Flow Cabinets (LFCs). While these cabinets may appear similar and both rely on HEPA filtration, they are designed for distinctly different purposes.
|
|
| |  | | | | |  Solving a 50-year Bottleneck in Chemotherapy Drug Production A multinational team of researchers has made a significant advance in the manufacturing of doxorubicin, a crucial chemotherapy drug. | | | | | | |  Cambridge’s LED breakthrough reinvents drug synthesis Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals – a discovery that could accelerate and improve how medicines are designed and made. | | | | | | |  Scientists turn plastic waste into Parkinson’s drug levodopa using engineered bacteria Researchers engineered a two-strain microbial system that converts PET-derived terephthalic acid into levodopa, overcoming key bottlenecks in transport and enzyme inhibition. The proof-of-concept process achieves high yields under mild conditions and demonstrates a potential route for upcycling plastic waste into valuable pharmaceuticals. | | | | | | |  Leading CROs and CDMOs turn to mass photometry for rapid protein, mRNA and viral vector analytics Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). | |
|
|
| | | | How would you rate today's newsletter?
| |
|
|
| | | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|
|
|
|
